These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8242229)

  • 1. Reduction in the number of thromboxane receptors on human platelets after exposure to GR32191.
    Armstrong RA; Humphrey PP; Lumley P
    Br J Pharmacol; 1993 Oct; 110(2):548-52. PubMed ID: 8242229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of the binding of [3H]-GR32191 to the thromboxane (TP-) receptor of human platelets.
    Armstrong RA; Humphrey PP; Lumley P
    Br J Pharmacol; 1993 Oct; 110(2):539-47. PubMed ID: 8242228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.
    Lumley P; White BP; Humphrey PP
    Br J Pharmacol; 1989 Jul; 97(3):783-94. PubMed ID: 2527074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
    Watts IS; Wharton KA; White BP; Lumley P
    Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibitory effect of GR32191, a thromboxane receptor blocking drug, on human platelet aggregation, adhesion and secretion.
    Hornby EJ; Foster MR; McCabe PJ; Stratton LE
    Thromb Haemost; 1989 Jun; 61(3):429-36. PubMed ID: 2529661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding and function of a potent new thromboxane receptor antagonist, BMS 180,291, in human platelets.
    Webb ML; Liu EC; Monshizadegan H; Hedberg A; Misra RN; Goldenberg H; Harris DN
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1387-94. PubMed ID: 8450473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of GR32191 and other thromboxane receptor blocking drugs on human platelet deposition onto de-endothelialized arteries.
    Foster MR; Hornby EJ; Stratton LE
    Thromb Res; 1992 Mar; 65(6):769-84. PubMed ID: 1386166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the mechanism of the prolonged action in man of GR32191, a thromboxane receptor antagonist.
    Ritter JM; Doktor HS; Benjamin N; Barrow SE; Stewart-Long P
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():351-4. PubMed ID: 1825568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of the thromboxane receptor alpha, the predominant isoform expressed in human platelets.
    Habib A; FitzGerald GA; Maclouf J
    J Biol Chem; 1999 Jan; 274(5):2645-51. PubMed ID: 9915793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary assessment of a novel thromboxane A2 receptor-blocking drug, GR32191, in healthy subjects.
    Thomas M; Lumley P
    Circulation; 1990 Jan; 81(1 Suppl):I53-8; discussion I59-60. PubMed ID: 2136818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
    Krauss AH; Woodward DF; Gibson LL; Protzman CE; Williams LS; Burk RM; Gac TS; Roof MB; Abbas F; Marshall K; Senior J
    Br J Pharmacol; 1996 Mar; 117(6):1171-80. PubMed ID: 8882612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DuP 753, the selective angiotensin II receptor blocker, is a competitive antagonist to human platelet thromboxane A2/prostaglandin H2 (TP) receptors.
    Liu EC; Hedberg A; Goldenberg HJ; Harris DN; Webb ML
    Prostaglandins; 1992 Aug; 44(2):89-99. PubMed ID: 1438880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of (5Z)-7-[3-endo-[(4-iodophenylsulfonyl) amino] -bicyclo[2.2.1]hep-2-exo-yl]heptenoic acid (IS-145) as an antagonist for the study of thromboxane A2 receptor.
    Kan WM; Tai HH
    Prostaglandins Leukot Essent Fatty Acids; 1993 Jun; 48(6):439-45. PubMed ID: 8341721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and localization of thromboxane A2 receptor in human and guinea-pig nasal mucosa using radiolabelled (+)-S-145.
    Arimura A; Miwa M; Hasegawa H; Kishino J; Notoya M; Yasui K; Komori M; Iwata S
    Br J Pharmacol; 1998 Jun; 124(4):795-803. PubMed ID: 9690873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
    Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
    J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
    Vezza R; Mezzasoma AM; Venditti G; Gresele P
    Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiological actions of thromboxane A2 and their pharmacological antagonism by thromboxane receptor blockade with GR32191.
    Humphrey PP; Hallet P; Hornby EJ; Wallis CJ; Collington EW; Lumley P
    Circulation; 1990 Jan; 81(1 Suppl):I42-52; discussion I59-60. PubMed ID: 2136817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of [5,6-3H]SQ 29,548 as a high affinity radioligand, binding to thromboxane A2/prostaglandin H2-receptors in human platelets.
    Hedberg A; Hall SE; Ogletree ML; Harris DN; Liu EC
    J Pharmacol Exp Ther; 1988 Jun; 245(3):786-92. PubMed ID: 2968449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S; Nakahata N; Ohizumi Y
    Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor binding properties of the new and specific thromboxane receptor antagonist Bay U 3405.
    Darius H; Michael-Hepp J; Meyer J
    Agents Actions Suppl; 1992; 37():157-61. PubMed ID: 1385923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.